Phase transformations of amlodipine besylate solid forms

Journal of Pharmaceutical Sciences

Volumn 100, Issue 7, 2011, Pages 2896-2910

  Koradia, Vishal ^a   Fontelonga de Lemos, Ana Filipa ^a,b   Allesø, Morten ^a,c   Lopez de Diego, Heidi ^c   Ringkjøbing Elema, Michiel ^c   Müllertz, Anette ^a   Rantanen, Jukka ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF PORTO   (Portugal)

^c H LUNDBECK A S   (Denmark)

Author keywords

Desolvation; Hydrate; Near infrared spectroscopy; Processing; Pseudopolymorphism; Raman spectroscopy; Solid dosage form; Solubility; Transition; Water in solids

Indexed keywords

AMLODIPINE BESYLATE;

ARTICLE; CONTROLLED STUDY; DRUG MIXTURE; DRUG SOLUBILITY; DRUG TRANSFORMATION; MICROSCOPY; MULTIVARIATE ANALYSIS; NEAR INFRARED SPECTROSCOPY; RAMAN SPECTROMETRY; SOLID STATE;

EID: 79955634809     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22509     Document Type: Article

References (32)

1. Morris KR, Griesser UJ, Eckhardt CJ, Stowell JG. 2001. Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes. Adv Drug Deliv Rev 48:91-114.
2. York P. 1983. Solid-state properties of powders in the formulation and processing of solid dosage forms. Int J Pharm 14:1-28.
3. Zhang GGZ, Law D, Schmitt EA, Qiu Y. 2004. Phase transformation considerations during process development and manufacture of solid oral dosage forms. Adv Drug Deliv Rev 56:371-390.
4. Wardrop J, Law D, Qiu Y, Engh K, Faitsch L, Ling C. 2006. Influence of solid phase and formulation processing on stability of Abbott-232 tablet formulations. J Pharm Sci 95:2380-2392.
5. Li X, Zhi F, Hu Y. 2007. Investigation of excipient and processing on solid phase transformation and dissolution of ciprofloxacin. Int J Pharm 328:177-182.
6. Seadeek C, Ando H, Bhattachar SN, Heimbach T, Sonnenberg JL, Blackburn AC. 2007. Automated approach to couple solubility with final pH and crystallinity for pharmaceutical discovery compounds. J Pharm Biomed Anal 43:1660-1666.
7. Tian F, Sandler N, Aaltonen J, Lang C, Saville DJ, Gordon KC, Strachan CJ, Rantanen J, Rades T. 2007. Influence of polymorphic form, morphology, and excipient interactions on the dissolution of carbamazepine compacts. J Pharm Sci 96:584-594.
8. Wikström H, Marsac PJ, Taylor LS. 2005. In-line monitoring of hydrate formation during wet granulation using Raman spectroscopy. J Pharm Sci 94:209-219.
9. Jørgensen A, Rantanen J, Karjalainen M, Khriachtchev L, Räsänen E, Yliruusi J. 2002. Hydrate formation during wet granulation studied by spectroscopic methods and multivariate analysis. Pharm Res 19:1285-1291.
10. Heinz A, Strachan CJ, Gordon KC, Rades T. 2009. Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy. J Pharm Pharmacol 61:971-988.
11. Jørgensen AC, Strachan CJ, Pollanen KH, Koradia V, Tian F, Rantanen J. 2009. An insight into water of crystallization during processing using vibrational spectroscopy. J Pharm Sci 98:3903-3932.
12. Wikström H, Carroll WJ, Taylor LS. 2007. Manipulating theophylline monohydrate formation during high-shear wet granulation through improved understanding of the role of pharmaceutical excipients. Pharm Res 25:923-935.
13. Davis TD, Peck GE, Stowell JG, Morris KR, Byrn SR. 2004. Modeling and monitoring of polymorphic transformations during the drying phase of wet granulation. Pharm Res 21:860-866.
14. Jørgensen AC, Airaksinen S, Karjalainen M, Luukkonen P, Rantanen J, Yliruusi J. 2004. Role of excipients in hydrate formation kinetics of theophylline in wet masses studied by near-infrared spectroscopy. Eur J Pharm Biopharm 23:99-104.
15. Airaksinen S, Luukkonen P, Jørgensen A, Karjalainen M, Rantanen J, Yliruusi J. 2003. Effects of excipients on hydrate formation in wet masses containing theophylline. J Pharm Sci 92:516-528.
16. Rantanen J, Wikström H, Rhea FE, Taylor LS. 2005. Improved understanding of factors contributing to quantification of anhydrate/hydrate powder mixtures. Appl Spectrosc 59:942-951.
17. Koradia V, Lopez de Diego H, Frydenvang K, Ringkjøbing-Elema M, Müllertz A, Bond AD, Rantanen J. Solid forms of amlodipine besylate: Physicochemical, structural, and thermodynamic characterization. Cryst Growth Des 10:5279-5290.
18. Braun DE, Maas SG, Zencirci N, Langes C, Urbanetz NA, Griesser UJ. Simultaneous quantitative analysis of ternary mixtures of d-mannitol polymorphs by FT-Raman spectroscopy and multivariate calibration models. Int J Pharm 385:29-36.
19. Kogermann K, Aaltonen J, Strachan CJ, Pollanen K, Heinamaki J, Yliruusi J, Rantanen J. 2008. Establishing quantitative in-line analysis of multiple solid-state transformations during dehydration. J Pharm Sci 97:4983-4999.
20. Chieng N, Rehder S, Saville D, Rades T, Aaltonen J. 2009. Quantitative solid-state analysis of three solid forms of ranitidine hydrochloride in ternary mixtures using Raman spectroscopy and X-ray powder diffraction. J Pharm Biomed Anal 49:18-25.
21. Heinz A, Savolainen M, Rades T, Strachan CJ. 2007. Quantifying ternary mixtures of different solid-state forms of indomethacin by Raman and near-infrared spectroscopy. Eur J Pharm Sci 32:182-192.
22. Mereiter K, Rollinger J. 2002. Private communication to the CCDC. Deposition no. 190882.
23. Nørgaard L, Saudland A, Wagner J, Nielsen JP, Munck L, Engelsen SB. 2000. Interval partial least-squares regression (iPLS): A comparative chemometric study with an example from near-infrared spectroscopy. Appl Spectrosc 54:413-419.
24. Taylor LS, Langkilde FW. 2000. Evaluation of solid-state forms present in tablets by Raman spectroscopy. J Pharm Sci 89:1342-1353.
25. Wikström H, Lewis IR, Taylor LS, Appl Spectrosc 2005:59, 934-941.
26. Rodríguez-Hornedo N, Lechuga-Ballesteros D, Hsiu-Jean W. 1992. Phase transition and heterogeneous/epitaxial nucleation of hydrated and anhydrous theophylline crystals. Int J Pharm 85:149-162.
27. Tian F, Sandler N, Gordon KC, McGoverin CM, Reay A, Strachan CJ, Saville DJ, Rades T. 2006. Visualizing the conversion of carbamazepine in aqueous suspension with and without the presence of excipients: A single crystal study using SEM and Raman microscopy. Eur J Pharm Biopharm 64:326-335.
28. Zimmermann A, Tian F, de Diego HL, Elema MR, Rantanen J, Müllertz A, Hovgaard L. 2009. Influence of the solid form of siramesine hydrochloride on its behavior in aqueous environments. Pharm Res 26:846-854.
29. Cardew PT, Davey RJ. 1985. The kinetics of solvent-mediated phase transformations. Proc R Soc Lond A 398:415-428.
30. Mullin JW. 2004. Crystallization. Oxford, UK: Elsevier Butterworth-Heinemann.
31. Gu CH, Young V, Grant DJ. 2001. Polymorph screening: Influence of solvents on the rate of solvent-mediated polymorphic transformation. J Pharm Sci 90:1878-1890.
32. Lester C, Lubey G, Dicks M, Andol G, Vaughn D, Cambron RT, Poiesz K, Redman-Furey N. 2006. Dehydration of risedronate hemi-pentahydrate: Analytical and physical characterization. J Pharm Sci 95:2631-2644.